Opioid use disorder is characterised by the persistent use of opioids despite the adverse
consequences of its use. The disorder is associated with a range of mental and general …

The opioid crisis has grown to affect pregnant women and infants across the United States,
as evidenced by rising rates of opioid use disorder among pregnant women and neonatal …

Background Although clinicians have traditionally used the Finnegan Neonatal Abstinence
Scoring Tool to assess the severity of neonatal opioid withdrawal, a newer function-based …

The opioid crisis in the United States has come about because of excessive use of these
drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use …

Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2 per 1000
births in 2000 to 5.8 per 1000 births in 2012. Symptoms in neonates may include high …

Importance The opioid epidemic increasingly affects pregnant women and developing
fetuses, resulting in high rates of neonatal abstinence syndrome. However, longitudinal …

OBJECTIVE To Address challenges in clinical care, quality improvement, research, and
public policy for prenatally opioid-exposed neonates by standardizing the clinical definition …

Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Importance The number of children with prenatal opioid exposure to medication for addiction
treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is …

Objectives: Identify the etiology and epidemiology of neonatal abstinence syndrome.
Describe the typical presentation, evaluation options, and assessment tools for neonatal …